BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18466265)

  • 1. Increased frequency and range of sexual behavior in a patient with Parkinson's disease after use of pramipexole: a case report.
    Munhoz RP; Fabiani G; Becker N; Teive HAG
    J Sex Med; 2009 Apr; 6(4):1177-1180. PubMed ID: 18466265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological gambling plus hypersexuality in restless legs syndrome: a new case.
    d'Orsi G; Demaio V; Specchio LM
    Neurol Sci; 2011 Aug; 32(4):707-9. PubMed ID: 21567182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compulsive drumming induced by dopamine agonists in Parkinson's disease: Another aspect of punding.
    Vitale C; Trojano L; Barone P; Errico D; Agosti V; Sorrentino G; Grossi D; Santangelo G
    Behav Neurol; 2013 Jan; 27(4):559-62. PubMed ID: 23242361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease.
    Bostwick JM; Hecksel KA; Stevens SR; Bower JH; Ahlskog JE
    Mayo Clin Proc; 2009 Apr; 84(4):310-6. PubMed ID: 19339647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.
    Moore TJ; Glenmullen J; Mattison DR
    JAMA Intern Med; 2014 Dec; 174(12):1930-3. PubMed ID: 25329919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of dopamine agonists on compulsive behaviors: a case series of pramipexole-induced pathological gambling.
    Kolla BP; Mansukhani MP; Barraza R; Bostwick JM
    Psychosomatics; 2010; 51(3):271-3. PubMed ID: 20484726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine agonist induced compulsive eating behaviour in a Parkinson's disease patient.
    Khan W; Rana AQ
    Pharm World Sci; 2010 Apr; 32(2):114-6. PubMed ID: 20039208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
    Garcia-Ruiz PJ; Martinez Castrillo JC; Alonso-Canovas A; Herranz Barcenas A; Vela L; Sanchez Alonso P; Mata M; Olmedilla Gonzalez N; Mahillo Fernandez I
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):840-4. PubMed ID: 24434037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies.
    Hassan A; Bower JH; Kumar N; Matsumoto JY; Fealey RD; Josephs KA; Ahlskog JE
    Parkinsonism Relat Disord; 2011 May; 17(4):260-4. PubMed ID: 21310646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compulsive habits in restless legs syndrome patients under dopaminergic treatment.
    Pourcher E; Rémillard S; Cohen H
    J Neurol Sci; 2010 Mar; 290(1-2):52-6. PubMed ID: 19969309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathological gambling and Parkinson disease].
    Fujimoto K
    Brain Nerve; 2008 Sep; 60(9):1039-46. PubMed ID: 18807938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease.
    Ahlskog JE
    Physiol Behav; 2011 Jul; 104(1):168-72. PubMed ID: 21557955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists.
    Bienfait KL; Menza M; Mark MH; Dobkin RD
    J Clin Neurosci; 2010 Apr; 17(4):539-40. PubMed ID: 20171891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effects of pramipexole on REM sleep behavior disorder in Parkinson disease.
    Kumru H; Iranzo A; Carrasco E; Valldeoriola F; Marti MJ; Santamaria J; Tolosa E
    Sleep; 2008 Oct; 31(10):1418-21. PubMed ID: 18853939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersexuality due to dopaminergic drugs.
    Prescrire Int; 2005 Dec; 14(80):224. PubMed ID: 16400746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and clinical characteristics of hypersexuality in patients with Parkinson's disease following dopaminergic therapy: A systematic literature review.
    Nakum S; Cavanna AE
    Parkinsonism Relat Disord; 2016 Apr; 25():10-6. PubMed ID: 26923525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label conversion study of pramipexole to ropinirole prolonged release in Parkinson's disease.
    Lyons KE; Pahwa R
    Mov Disord; 2009 Oct; 24(14):2121-7. PubMed ID: 19768728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impulse control disorder behaviors associated with pramipexole used to treat fibromyalgia.
    Holman AJ
    J Gambl Stud; 2009 Sep; 25(3):425-31. PubMed ID: 19241148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?
    van Eimeren T; Ballanger B; Pellecchia G; Miyasaki JM; Lang AE; Strafella AP
    Neuropsychopharmacology; 2009 Dec; 34(13):2758-66. PubMed ID: 19741594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine dysregulation syndrome in Parkinson's disease patients with unsatisfactory switching from immediate to extended release pramipexole: a further clue to incentive sensitization mechanisms?
    Solla P; Cannas A; Corona M; Marrosu MG; Marrosu F
    Behav Neurol; 2013 Jan; 27(4):563-6. PubMed ID: 23242362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.